(Q34777570)

4 August 2017

title

Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study (English)

1 reference

4 August 2017

0 references

Luca Guarda-Nardini

1

1 reference

4 August 2017

Daniele Manfredini

2

1 reference

4 August 2017

Milena Salamone

3

1 reference

4 August 2017

Luigi Salmaso

4

1 reference

4 August 2017

Stefano Tonello

5

1 reference

4 August 2017

Giuseppe Ferronato

6

1 reference

4 August 2017

publication date

1 April 2008

1 reference

Cranio: Journal of Craniomandibular Practice

4 August 2017

published in

1 reference

4 August 2017

volume

26

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

126-135

1 reference

Research diagnostic criteria for temporomandibular disorders (RDC/TMD) axis I diagnoses in an Italian patient population

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

History and evolution of TMD concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Sleep bruxism; an overview of an oromandibular sleep movement disorder. REVIEW ARTICLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Bruxism is mainly regulated centrally, not peripherally

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Sleep bruxism as a motor disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Neurobiological mechanisms involved in sleep bruxism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

The relationship of bruxism with craniofacial pain and symptoms from the masticatory system in the adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Oral splints: the crutches for temporomandibular disorders and bruxism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Widespread pain and the effectiveness of oral splints in myofascial face pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Effectiveness of exercise therapy in patients with myofascial pain dysfunction syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Pharmacologic treatments for temporomandibular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Amitriptyline treatment of chronic pain in patients with temporomandibular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Complementary and alternative medicine: impact on dentistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

The use of botulinum toxin for the treatment of chronic facial pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Headache and botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Pharmacology of botulinum toxin: differences between type A preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Botulinum toxin type A for treating voice tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

The role of parafunctions, emotions and stress in predicting facial pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Treatment of severe temporomandibular joint clicking with botulinum toxin in the lateral pterygoid muscle in two cases of anterior disc displacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

Severe amphethamine-induced bruxism: treatment with botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FCRN.2008.017

21 January 2018

Identifiers

DOI

10.1179/CRN.2008.017

0 references

1 reference